Top Abstract Purchase Related
Home
>
Node
>
Subnode

Bone and bone related biochemical examinations. Bone and collagen related metabolites. Measurement of PICP and PINP in the evaluation of pharmaceutical treatment efficacy for osteoporosis

Nakatsuka, K.; Nishizawa, Y.; Miura, M.

Clinical Calcium 16(6): 977-985

2006

ISSN/ISBN: 0917-5857
PMID: 16751694
Document Number: 601689
Propeptides of type I procollagen are generated during the process of collagen formation in bone matrix. Among them measurements of circulating N-terminal propeptide (PINP) has been recognized as one of promising metabolic bone markers in the assessment of efficacy of pharmaceutical intervention for osteoporosis. Recently assays of PINP have been established to be supplied as measurement kits following those of C-terminal propeptide (PICP) and clinical data on usefulness of PINP in the evaluation of teriparatide an anabolic agent as well as various anti-catabolic agents have accumulated. Therefore, the measurement of PINP must be an essential tool in Japan at the time when newer agents for osteoporosis are applied to clinical practice in the future.

Document emailed within 1 workday
Secure & encrypted payments

Sasaki, N.; Kusano, E. 2006: Bone and bone related biochemical examinations. Bone and collagen related metabolites. Measurement and clinical role of OPG Clinical Calcium 16(6): 956-962
Sajdak, S.; Krawczyk, J.; Piatek, J.; Kopczyński, Z. 2000: The applicability of biochemical markers of bone metabolism for predicting the risk of bone fractures and for the assessment of bone tissue resorption in the course of osteoporosis Clinical and Experimental Obstetrics and Gynecology 27(2): 118-120
Kobayashi, Y.; Tokue, A. 1998: Clinical usefulness of blood PICP, PINP and ICTP concentrations as bone metastasis markers in prostate cancer patients Nihon Rinsho. Japanese Journal of Clinical Medicine 56(8): 2072-2076
Hasegawa, M.; Ichimura, S.; Satomi, K. 2010: Effects of SERMs on bone health. the evaluation of raloxifene treatment for elderly women with osteoporosis using bone turnover markers Clinical Calcium 20(3): 413-420
Delmas, P.D.; Wahner, H.W.; Mann, K.G.; Riggs, B.L. 1983: Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein Journal of Laboratory and Clinical Medicine 102(4): 470-476
Franke, S.; Lehmann, G.; Abendroth, K.; Hein, G.; Stein, G. 1998: PICP as bone formation and NTx as bone resorption marker in patients with chronic renal failure European Journal of Medical Research 3(1-2): 81-88
Aujla, K.; Majithia, V. 2016: Assessment of Secondary Causes of Osteoporosis and Racial Differences in Men with Normal vs. Abnormal Bone Mineral Density in a Cohort of Men Undergoing Bone Mass Measurement Journal of the Mississippi State Medical Association 57(9): 285-288
Tolino, A.; Romano, L.; Ronsini, S.; Riccio, S.; Montemagno, U. 1993: Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns International Journal of Clinical Pharmacology Therapy and Toxicology 31(7): 358-360
Zou, T.; Yan, J.; Fu, H.; Hou, Z.; Wang, S.; Xia, J. 2005: Combined use of autologous micro-morselized bone with bone morphogenetic protein and type i collagen graft in repairing rabbit bone defects Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 19(3): 187-191
Saito, M. 2006: Poor bone quality in diabetes: detrimental collagen cross-link pattern reduces bone strength without change in bone mineral density Clinical Calcium 16(8): 1287-1295
Boonyanurak, P.; Wilawan, K. 2009: Levels of biochemical bone marker procollagen type i N-propeptide (PINP) in Thai women aged 40-70 years Journal of the Medical Association of Thailand 92(7): 873-877
Shibata, Y.; Miyazaki, T. 2017: New methods for the evaluation of bone quality. Nanoindentation protocol for measurement of bone mechanical properties of material level Clinical Calcium 27(8): 1139-1145
Takahashi, H.; Maruyama, K.; Shigeta, Y.; Takagi, T.; Okuyama, K.; Horie, Y.; Miyaguchi, S.; Muraoka, H.; Takagi, S. 1991: Vertebral bone density and its correlation with various factors related to bone metabolism in alcoholics: a quantitative study by computed tomography Arukoru Kenkyu to Yakubutsu Izon 26(6): 489-499
Yamauchi, M. 2009: Biochemical markers of bone turnover. new aspect. Biochemical bone markers of bone in patients treated with glucocorticoid Clinical Calcium 19(8): 1092-1100
Ihle, B.U.; Becker, G.J.; Kincaid-Smith, P.S. 1986: Clinical and biochemical features of aluminum-related bone disease Kidney International. Suppl 18: S80-S86
Kiryłów, E.; Kamiński, G. 2008: Place of biochemical markers of bone turnover in guidelines for diagnosis and treatment of osteoporosis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 25(148): 386-389
Schrøder, H.; Clausen, N.; Thorling, K.; Hokland, P. 1993: Autologous bone marrow transplantation in children with malignant diseases. Bone marrow harvest and procedure-related toxicity Ugeskrift for Laeger 155(20): 1536-1539
Michelsson, J.E.; Pettilä, M.; Valtakari, T.; Leivo, I.; Aho, H.J. 1994: Isolation of bone from muscles prevents the development of experimental callus-like heterotopic bone. A study of the interaction of bone and muscle in new bone formation Clinical Orthopaedics and Related Research 1994(302): 266-272
Iguchi, H.; Tanaka, S.; Ozawa, Y.; Kashiwakuma, T.; Kimura, T.; Hiraga, T.; Ozawa, H.; Kono, A. 1996: An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis Cancer Research 56(17): 4040-4043
Parfitt, A.M. 1988: The localization of aluminum in bone: implications for the mechanism of fixation and for the pathogenesis of aluminum-related bone disease International Journal of Artificial Organs 11(2): 79-90